348 related articles for article (PubMed ID: 15966635)
1. The DEA issues new clarification regarding prescribing schedule II controlled substances.
Heitz R
WMJ; 2005 Apr; 104(3):55. PubMed ID: 15966635
[No Abstract] [Full Text] [Related]
2. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
[TBL] [Abstract][Full Text] [Related]
3. DEA issues proposed rule on e-prescribing.
Ball FR
J Med Pract Manage; 2009; 24(4):243. PubMed ID: 19288650
[TBL] [Abstract][Full Text] [Related]
4. The DEA proposes schedule II substance rule.
Buchanan BL
WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715
[No Abstract] [Full Text] [Related]
5. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
[TBL] [Abstract][Full Text] [Related]
6. Dear DEA.
Heit HA; Covington E; Good PM
Pain Med; 2004 Sep; 5(3):303-8. PubMed ID: 15367311
[No Abstract] [Full Text] [Related]
7. The Drug Enforcement Agency and DEA Form 104.
Stratton WT
Kans Med; 1994 Oct; 95(10):212, 214. PubMed ID: 7815771
[No Abstract] [Full Text] [Related]
8. Controlled substances in long-term care pharmacy: part 2.
Martin CM
Consult Pharm; 2008 Oct; 23(10):742-56. PubMed ID: 19032014
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for prescribers of controlled substances. A joint statement of the Drug Enforcement Administration and the DEA/Practitioners Working Committee.
J Conn State Dent Assoc; 1981 Mar; 55(1):18-9. PubMed ID: 6785326
[No Abstract] [Full Text] [Related]
10. Facsimile transmission of prescriptions for patients enrolled in hospice programs. Drug Enforcement Administration (DEA), Justice. Final rule.
Fed Regist; 2001 Jan; 66(8):2214-5. PubMed ID: 11503757
[TBL] [Abstract][Full Text] [Related]
11. Pharmacists correcting schedule II prescriptions: DEA flip-flops continue.
Abood RR
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):393-6. PubMed ID: 21133749
[TBL] [Abstract][Full Text] [Related]
12. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
[TBL] [Abstract][Full Text] [Related]
13. What is being done to address the new drug epidemic?
Dekker AH
J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
[TBL] [Abstract][Full Text] [Related]
14. Doctors with multi-state practices beware: new DEA regulation could affect you.
Ball FR
J Med Pract Manage; 2007; 23(2):104-5. PubMed ID: 17974088
[No Abstract] [Full Text] [Related]
15. Guidelines for prescribers of controlled substances.
Wis Med J; 1981 Jun; 80(6):53-4. PubMed ID: 7257443
[No Abstract] [Full Text] [Related]
16. Programs for monitoring inappropriate prescribing of controlled drugs: evaluation and recommendations.
Collins TM; Zimmerman DR
Am J Hosp Pharm; 1992 Jul; 49(7):1765-8. PubMed ID: 1621738
[No Abstract] [Full Text] [Related]
17. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies.
Drug Enforcement Adminstration U S Department of Justice
J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229
[TBL] [Abstract][Full Text] [Related]
18. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
[TBL] [Abstract][Full Text] [Related]
19. Should the DEA conduct a "patient impact assessment" when promulgating new restrictions on controlled substance distribution?
Brushwood DB
J Pain Palliat Care Pharmacother; 2008; 22(4):322-6. PubMed ID: 21923319
[TBL] [Abstract][Full Text] [Related]
20. Effect of a triplicate prescription law on prescribing of Schedule II drugs.
Sigler KA; Guernsey BG; Ingrim NB; Buesing AS; Hokanson JA; Galvan E; Doutré WH
Am J Hosp Pharm; 1984 Jan; 41(1):108-11. PubMed ID: 6695926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
